We're working on profiling this company soon. Let us know you're interested by sending us a request here »
We're working hard to bring you this company's profile. Register here to get an alert as soon we're done.
In the meantime, if you are interested in participating in placements on this stock click "Follow" on the toolbar above.
Impedimed and Avita Medical have won a ‘pay rise’ from private and public US payors Orthocell posts...
Read ArticleAmid soaring global tensions, investors have flocked to the best known local defence stocks ASX-lis...
Read ArticleThe S&P ASX 200 Health Care index fell 13.21% in August as a tough reporting season weighed on...
Read ArticleDimerix boss Dr Nina Webster to join Imagion Biosystems as non-executive director Webster has exten...
Read ArticleThe S&P ASX 200 Health Care index rose 9.05% in July with rotation into the sector gaining mome...
Read ArticleImmuron shares surge more than 30% on robust sales of the company’s traveller’s trots prophylactic...
Read ArticleThe ASX 200 Health Care Index fell 1.05% in June and remains the worst performing sector YTD down 6...
Read ArticleThe S&P/ASX 200 Health Care Index rose 1.59% in May but remains worst performing sector YTD dow...
Read ArticleAs a former bus driver, Dimerix (ASX:DXB) CEO Dr Nina Webster knows that the drug development journe...
Read ArticleThe US health sector shows signs of stabilising as chaos subsides Immutep will meet with the FDA fo...
Read ArticleThe S&P/ASX 200 Health Care Index rose 2.16% in April with the S&P/ASX 200 rallying 3.6% Mo...
Read ArticleThe S&P/ASX 200 Health Care Index fell 7.66% in February with the S&P/ASX 200 down 3.79% Mo...
Read ArticleBanks fall, mining stocks rise Rio Tinto in mega merger talks, suggests Bloomberg China hits 5pc gr...
Read ArticleImmuron Ltd (ASX:IMC) has moved through a series of development milestones for its drug Travelan: wh...
Read ArticleThe S&P/ASX 200 Health Care Index fell 1.85% in December but rose 7.51% overall in 2024 Mesobl...
Read ArticleThe S&P/ASX 200 Health Care Index rose 2.89% in November as momentum returned to the sector Hea...
Read ArticleHarvard University’s teaching hospital will adopt Echo IQ’s AI-based aortic stenosis detection tool...
Read ArticleASX healthcare stocks underperform but optimism grows Uscom, Respiri and Hitiq report mixed results...
Read ArticleASX rises as banking and tech sectors lead gains Arcadium Lithium surges on potential acquisition...
Read ArticleASX edges down in a quiet market Pilbara Minerals falls 5pc as share block sale is reported We...
Read ArticleHealthcare stocks are doing relatively well globally in 2024 The sector could see more recovery as...
Read ArticleASX health stocks down in August and trail the broader market in 2024 CSL up 6,000pc since listing;...
Read ArticleS&P/ASX 200 Health Care index up 5pc in July, 9.5pc YTD Health sector gains momentum with expec...
Read ArticleThe EMA has rejected the Alzheimer’s drug Leqembi, developed by Eisai and Biogen There is one ASX-l...
Read ArticleMomentum trading involves buying rising stocks and selling falling ones This works best during econ...
Read ArticleThe ASX Health Care index saw a 4% increase in June Growth was driven by CSL and Cochlear Best biot...
Read ArticleIMM files a pre-IND application with US FDA for IMM-529 targeting common pathogen clostridioides di...
Read ArticleS&P/ASX 200 Health Care closed flat in May 2024 brings challenges, but hopes are high for biot...
Read ArticleResearch shows Alzheimer’s is entirely preventable A poor diet and bad gut bacteria can increase th...
Read ArticleSteve Lydeamore’s advice to biotech peers seeking to do business with the US military is to be armed...
Read ArticleMomentum trading involves taking advantage of, and making profits from, upward trends in a stock. Th...
Read ArticleASX Health sector was in correction territory in April Why is the health sector different from othe...
Read ArticleThere’s been a breakthrough in acne treatment Scientists have found a way to use skin bacteria to c...
Read ArticleLocal markets gives up early gains, ekes out 0.1pc advantage IT and Utilities offset by Energy se...
Read ArticleMomentum trading involves taking advantage of, and making profits from, upward trends in a stock. It...
Read ArticleThis week’s Bulls N’ Bears top ASX runner is… Macro Metals. Its share price rose more than 166 per c...
Read ArticleStockhead’s Top 10 at 11, published each trading day, highlights the best (and worst) performing ASX...
Read ArticleThe ASX200 closed up 0.4 per cent. Industrials & IT led the ranks – both up more than a per c...
Read ArticleThe ASX 200 lifted modestly by +0.2% on Thursday as gains in Tech and Industrial stocks were offset...
Read ArticleThe ASX200 has been trading up 0.18 per cent to just above 7,745 points – not by the nearly half a p...
Read Article07 Mar 2024 - A snapshot of the stocks on the move, featuring Dotz Nano (ASX:DTZ, OTC:DTZNY), Immuro...
Read ArticleImmuron jumps 80pc Travelan shown to be effective The trial is now set to to progress to Phase 3 Do...
Read ArticleAustralian biopharmaceutical company Immuron (ASX: IMC) has released interim topline results from a...
Read ArticleA little-known ASX healthcare stock is setting the bar sky-high today. In morning trade on Thursday...
Read ArticleTo register for Friday's webinar click here. Dotz Nano (ASX:DTZ, OTC:DTZNY), a leading developer o...
Read ArticleASX Health Index down -1.5% for February 76 biotechs rose, and 78 fell during the month But essenti...
Read ArticleViking Therapeutics doubled after results of weight loss drug trial Janux Therapeutics tripled on p...
Read ArticleImmuron reports record sales for Travelan in January Neurotech extends Phase 1/2 clinical trial for...
Read ArticleImmuron (ASX:IMC) has announced record sales of its over-the-counter immune supplement that...
Read ArticleXi and Biden set to agree on restricting fentanyl Fentanyl is a synthetic opioid responsible for t...
Read ArticleNews relating to Novo Nordisk’s Ozempic has led to a selloff in some ASX stocks CSL, FPH, and RMD f...
Read ArticleAsk any chief of a development-stage biotech about the prospect of a partnering or licencing deal an...
Read ArticleASX 200 closes higher for a fifth straight day All 11 Sectors make it home for supper Small caps l...
Read ArticleStockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might h...
Read ArticleL’Oréal to take minority stake in Chinese startup Shinehigh Innovation Shinehigh is developing supr...
Read ArticleThe FDA has just approved an emergency use authorisation for new Covid-19 vaccines What is emergenc...
Read ArticleStockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might h...
Read ArticleEarnings reports dominated headlines in August Despite solid results from ASX healthcare giants, th...
Read ArticleAustralian biotech has attracted US investments in the last five years Among ASX stocks to get fund...
Read ArticleBiotech could be a US$4 trillion industry in 10 years Genetic engineering and weight loss are two g...
Read ArticleImmuron (IMC) announces a 136 per cent increase in FY23 global sales on FY22 sales The sales of i...
Read ArticleCann Group’s FY23 sales were 2.1 times that of FY22 Immuron’s FY23 sales increased by 136% from the...
Read ArticleThe infectious diseases space is one area that could be interesting for ethical investors An ASX co...
Read ArticleBy Tim Boreham ASX code: ((DXB)) Share price: 7.0c Shares on issue: 320,748,666* Market cap: $22.5m...
Read ArticleBiotech is making a comeback in 2023 There’s been a couple of breakthroughs on the ASX this year We...
Read ArticleASX benchmark ends the day flat, but not for lack of trying to rise. Or fall Tech stocks fell hard...
Read ArticleThe market shows that biotechs are making a gradual comeback in 2023 What are some of the catalysts...
Read ArticleImmuron (ASX:IMC) has announced that the US Naval Medical Research Center has received appro...
Read ArticleLittle Green Pharma gets extended contract from the French government US FDA’s decision paves the w...
Read ArticleArtificial intelligence is set to disrupt the healthcare sector AI could also help in drugs discove...
Read ArticleShareCafeTech and mining shares lead ASX 0.25% lower at close by Peter Milios Technology and minin...
Read ArticleHealth care stocks have surged in early trade, up more than a per cent. Biotech company Immuron m...
Read ArticleShareCafeAus shares down 0.25% at noon as RBA warns of higher risk by Peter Milios The Reserve Ban...
Read ArticleImmuron (IMC) shares are rising after posting its Travelan and Protectyn sales figures for Q3 FY23...
Read ArticleShareCafeStocks of the Hour: IMC, WMG, CPM Australian based and globally in...
Read Article06 Apr 2023 - A snapshot of the stocks on the move featuring Immuron (ASX:IMC), Western Mines Group...
Read ArticleNoxopharm plunged 45pc after scaling down its Veyonda program Rhythm Biosciences rose 25pc after sa...
Read ArticleStockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) pe...
Read ArticleThe ASX is poised to open modestly lower on Thursday Tech stocks plummeted in the US overnight on r...
Read ArticleThe ASX is expected to slip on Thursday as eyes are once again on the Reserve Bank. The RBA is ex...
Read ArticleThe FDA declined regulate CBD-based supplements and food, citing safety reasons CBD products have g...
Read ArticleCynata Therapeutics’ chief medical officer, Jolanta Airey, gives a step-by-step guide on what biote...
Read ArticleJapanese startup OUI is on a mission to halve the world’s blindness with its smartphone-based devic...
Read ArticleImmuron (ASX:IMC) has updated on the US Department of Defense Uniformed Services University...
Read ArticleGood news is bad news for the US economy Aussie benchmark goes deep into a pre-Christmas shame spir...
Read ArticleImmuron’s (IMC) lands US Food and Drug Administration (FDA) approval for its investigational new dru...
Read ArticleASX health stocks have been out of favour this year with rotation away from growth to value sector...
Read ArticleWe take a look at how the 15 biotech IPOs that listed in 2021 are faring now Only two IPO stocks fr...
Read ArticleBlood clot programs have taken the spotlight recently as new discoveries made Two ASX health stocks...
Read ArticleDr Boreham’s Crucible By Tim Boreham ASX code: ((IIQ)) Share price: 67 cents Market cap: $59.8 milli...
Read ArticleImmuron (IMC) will deprioritise its SARS-COV-2 research to focus on the clinical development of its...
Read ArticleImmuron (ASX:IMC) has announced that the US Naval Medical Research Center has received feedb...
Read ArticleUS FDA approves the first clinical trial using naturally derived psychedelic drugs It could open po...
Read ArticleBiopharmaceutical company Immuron (IMC) sees a 494 per cent increase in North American Travelan sal...
Read ArticleA recent research reveals which biotech segments VCs are ploughing billions of dollars into We list...
Read ArticleImmuron (ASX:IMC) has announced that the US Naval Medical Research Center has submitted an I...
Read ArticleImmuron’s (IMC) travellers diarrhoea preventative medication Travelan is set to be tested for effic...
Read ArticleThe Healthcare sector has been struggling as the pandemic wanes But most money managers are still b...
Read ArticleThe healthcare sector is experiencing a dry run IPO listings have fallen significantly on weak mark...
Read ArticleBiotech sector has had a tough time recently But there are signs of things improving this year A lo...
Read ArticleHighlights The Australian healthcare sector includes companies engaged in biotechnology and rese...
Read ArticleTelehealth was already a growing space even before the pandemic, but COVID had launched it into the...
Read ArticleThe ongoing lawsuit involving Johnson & Johnson (J&J)’s talc products took a controversial t...
Read ArticleThings weren’t looking good ahead of the opening bell today, after a rough session for US stocks fol...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleThe Immuron Ltd (ASX: IMC) share price soared again today, trading up 16.67% at 14 cents near the m...
Read ArticleImmuron (IMC) is granted a European patent for compositions and methods for treating travellers’ di...
Read ArticleStockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) per...
Read ArticleASX investors got back in the risk saddle on Wednesday, with steady gains across the large cap index...
Read ArticleThe Australian share market has recovered after two days of losses with Energy and Materials stocks...
Read ArticleThe ASX has jumped out of the blocks this morning, as expected, after two consecutive days of losses...
Read ArticleImmuron nabs $6.2m clinical research deal for US Military strength Travelan dose ECS Botanics repor...
Read ArticleThe Immuron Ltd (ASX: IMC) share price is shooting out the lights on Wednesday following a positive...
Read ArticleStockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) per...
Read ArticleStockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) per...
Read ArticleStockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) per...
Read ArticleAt the time of writing, the ASX XHJ Healthcare index is up 5.55% over the last five trading days, be...
Read ArticleIt’s been a rocky two weeks for small-cap health companies with 42 gaining ground, 76 losing it, and...
Read ArticleThe life sciences sector has emerged into the spotlight ever since the pandemic began. In the US, th...
Read ArticleIt’s been a rocky two weeks for small-cap health companies, with 27 companies gaining ground, 89 los...
Read ArticleIt’s been a rocky two weeks for small-cap health companies, with 33 companies gaining ground, 86 los...
Read ArticleThe ASX 200 Health Index (XHJ) is up by 1.5% at the time of writing, compared to the broader index w...
Read ArticleImmuron (ASX:IMC) has announced the restart of its clinical development program that was tem...
Read ArticleThe ASX retreated again as angst over inflation and the withdrawal of stimulus continued to weigh on...
Read ArticleStockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) per...
Read ArticleThe ASX had a positive end to the week with the ASX 200 gaining 0.87% today taking its weekly gain t...
Read ArticleThe Immuron Ltd (ASX: IMC) share price is taking off today after it was found the company’s drug mi...
Read ArticleThe ASX 200 health stocks index (XHJ) had risen by 0.30% at the time of writing, compared to the bro...
Read ArticleImmuron (ASX:IMC) has announced it will not proceed with a previously announced acquisition...
Read ArticleThe ASX limped into the close on Friday, in a fairly tame finish to a roller-coaster week. Evergrand...
Read ArticleStockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) per...
Read ArticleAlthough earnings results were the main theme in August, there were also some notable healthcare bre...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with only 45 companies gaining ground, 7...
Read ArticleThe ASX 200 health stocks index is tracking the broader index well over the past two weeks. Both the...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with only 38 companies gaining ground, 7...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with 60 companies gaining ground and 52...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. The healthcare sector has ret...
Read ArticleThe ASX had a mixed day but closed narrowly in the green with a 0.03 per cent gain to 7,095 points w...
Read ArticleIt was a good day for some of ASX-listed cancer therapy stocks yesterday, with three companies relea...
Read ArticleClosing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers. Data is taken at th...
Read ArticleThe Immuron Ltd (ASX: IMC) share price is a strong performer on the ASX today. This follows the bio...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks f...
Read ArticleThe Immuron Ltd (ASX: IMC) share price closed over 4.4% lower today at 22 cents a share. The slide...
Read ArticleThe Immuron Ltd (ASX: IMC) share price is surging today following a research agreement with Monash...
Read ArticleSummary Dual-listed biopharmaceutical company Immuron Limited has entered a new research agreeme...
Read ArticleSummary The Naval Medical Research Center found promising results of Immuron Limited's vaccine fo...
Read ArticleThe Immuron Limited (ASX: IMC) share price is soaring today, up 18% in afternoon trading. This come...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleA quick wrap of the ASX’s key winners and losers on Wednesday, July 22. Data is taken after the mark...
Read ArticleAfter days of consecutive growth, the Immuron Limited (ASX: IMC) share price is falling today follo...
Read ArticleNew research indicates Imagion Biosystems’ (ASX: IBX) imaging particles could bring down Tesla — in...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleA quick wrap of the ASX’s key winners and losers on Tuesday, July 21. Data is taken after the market...
Read ArticleBiopharmaceutical company Immuron (ASX: IMC) has revealed the IMM-124E, which is used in its commerc...
Read ArticleNews that one of Immuron’s (ASX:IMC) drug candidates could take on COVID-19 has got investors in a f...
Read ArticleThe Immuron Limited (ASX: IMC) share price is up by 89.80% to 46 cents per share this morning on ne...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleThe Immuron Limited (ASX: IMC) share price is up by 6.86% on news that the U.S. Food and Drug admin...
Read ArticleWant to know which stocks the fund managers have been putting their money in (and out) of? We’ve bee...
Read ArticleA quick wrap of the key winners and losers on Monday, June 15. Data is taken after the market closes...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleA quick wrap of the key winners and losers on Wednesday, June 10. Data is taken after the market clo...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleDual-listed biopharmaceutical company Immuron (ASX: IMC) is on course to make progress with a new or...
Read ArticleFormer defence minister Christopher Pyne loves a gun pic — he’s one of the security industry’s bigge...
Read ArticleClinical trials are being shuttered in increasing numbers in Australia because of the risks posed by...
Read ArticleAustralian company Immuron (ASX:IMC) has updated investors on the impact of COVID-19 and ann...
Read ArticleIt’s an all-out bloodbath taking place on the ASX today. But amid the carnage, a few small-caps stil...
Read ArticleGastrointestinal diseases are among the most inconvenient types of illnesses to have, and not just b...
Read ArticleMicrobiome company Immuron (ASX: IMC) has posted a six-monthly unaudited gross revenue of $1.68 mill...
Read ArticleYou don’t need a PhD to run a biotech, but sometimes it helps, as these companies deal in one of the...
Read ArticleCancer is a crowded market, pot has sleep and pain issues covered — or so they say — and companies d...
Read ArticleThere are no shortage of small cap health and biotech companies listed on the ASX — around 140 or so...
Read ArticleInvesting in Small-Cap Stocks Biotech is a dynamic and profitable sector for investors. Capital vent...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleWhat's hot Immuron Limited (ASX:IMC) Immuron closed up 66% to finish at 17.5c on $3.69 million stock...
Read ArticleOn Stockhead today: are semiconductors about to pick up again, California’s first pot cafe opens, bi...
Read ArticleIt is not often that headlines on the ASX really stand out. Aside from the obvious mining hits, tech...
Read ArticleMicrobiome company Immuron (ASX: IMC), a firm that specialises in developing oral immunotherapeutic...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleImmuron Ltd (ASX:IMC; NASDQ: IMRN), an Australian biopharmaceutical company focused on developing an...
Read ArticleShares in biotech Orthocell (ASX:OCC) are on the move again today after the company reported further...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleIn delivering its annual report on Friday, Immuron Ltd (ASX:IMC) provided a promising update in rela...
Read ArticleOn 15 August 2019, the S&P/ASX 200 Health Care Index is down 2.48% to 34,883, while the benchmar...
Read ArticleShares in Immuron took a 17 per cent hit this morning after the company revealed its IMM-124E drug d...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleAustralian biopharmaceutical company,Immuron Limited (ASX: IMC), headquartered in Carlton, is engage...
Read ArticleImmuron (ASX:IMC), an Australian biopharmaceutical company focused on developing and commerc...
Read ArticleEven though the stock markets are sensitive to the global macro-economic parameters, in the present...
Read ArticleHealthcare Healthcare sector comprises of the companies that offer medical services, producing medi...
Read ArticleAussie biopharmaceutical company Immuron Limited [ASX:IMC] is thriving in the early hours of today’s...
Read ArticleImmuron (ASX: IMC) has revealed its full year 2019 revenue in North America had grown more than 50%...
Read ArticleIn this week’s recap of substantial holders, a Dubai executive bought into Prospect Resources (ASX:...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleAustralian biopharmaceutical group, Immuron Ltd (ASX:IMC; NASDQ:IMRN), has provided an extremely pro...
Read ArticleAustralian biopharmaceutical company Immuron (ASX: IMC) has reported positive results from a study d...
Read ArticleImmuron Limited (ASX:IMC | NASDAQ:IMRN) has provided a steady stream of positive news across its mic...
Read ArticleImmuron Limited (ASX:IMC | NASDAQ:IMRN) is focused on developing and commercialising orally delivere...
Read Article
Open an account with an online broker of your choice. If you do not have an existing broker, consider Vested Equities' A$9.50 flat fee platform.
Sign up now »Place your order however you wish. If you need advice on buying or selling, you should seek the assistance of a full service financial adviser experienced in small cap equities.
